1. Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin

   • Rundi Ma
   • Gang Song
   • Tingxi Yu

   Original Article Open access 21 November 2007 Pages: 559 - 568

   

2. c-Jun-NH₂-terminal kinase potentiates apoptotic cell death in response to carboplatin in B lymphoma cells

   • Eiko Takada
   • Kikumi Hata
   • Junichiro Mizuguchi

   Original Article 17 November 2007 Pages: 569 - 576

   

3. Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines

   • Noriaki Kitada
   • Kohji Takara
   • Teruyoshi Yokoyama

   Original Article 21 November 2007 Pages: 577 - 584

   

4. Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines

   • Songyot Anuchapreeda
   • Singkome Tima
   • Pornngarm Limtrakul

   Original Article 23 November 2007 Pages: 585 - 594

   

5. Biological properties of 4-methyl-2,7-diamino-5,10-diphenyl-4,9-diazapyrenium hydrogensulfate (ADAP)

   • Saška Marczi
   • Ljubica Glavaš-Obrovac
   • Mladen Žinić

   Original Article 23 November 2007 Pages: 595 - 604

   

6. Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice

   • Laura K. Zerbe
   • Lori D. Dwyer-Nield
   • Alvin M. Malkinson

   Original Article 21 November 2007 Pages: 605 - 620

   

7. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft

   • M. Bigioni
   • A. Benzo
   • M. Binaschi

   Original Article 24 November 2007 Pages: 621 - 629

   

8. A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors

   • Laura Q. M. Chow
   • S. Gail Eckhardt
   • Lia Gore

   Original Article 06 December 2007 Pages: 631 - 646

   

9. Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas

   • T. Clark Gamblin
   • Merrill J. Egorin
   • David L. Bartlett

   Original Article 27 November 2007 Pages: 647 - 653

   

10. Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide

    • Franca Formelli
    • Elena Cavadini
    • Stefano Persiani

    Original Article 08 December 2007 Pages: 655 - 665

    

11. Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel

    • Rosalba Torrisi
    • Alessandra Balduzzi
    • Marco Colleoni

    Original Article 07 December 2007 Pages: 667 - 672

12. A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma

    • M. Reni
    • R. Berardi
    • S. Grisanti

    Original Article 03 January 2008 Pages: 673 - 678

    

13. Pharmacokinetics of heated intraperitoneal oxaliplatin

    • G. Ferron
    • S. Dattez
    • E. Chatelut

    Original Article 15 December 2007 Pages: 679 - 683

    

14. Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients

    • Jens Atzpodien
    • Kerstin Terfloth
    • Martina Reitz

    Original Article 15 December 2007 Pages: 685 - 688

    

15. BRCA1 modulates sensitivity to 5F-203 by regulating xenobiotic stress-inducible protein levels and EROD activity

    • Hyo Jin Kang
    • Hee Jeong Kim
    • Insoo Bae

    Original Article 12 December 2007 Pages: 689 - 697

    

16. Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy

    • Danny Rogers
    • Karen D. Nylander
    • Nina F. Schor

    Original Article 13 March 2008 Pages: 699 - 706

    

17. Delineation of the interactions between the chemotherapeutic agent eribulin mesylate (E7389) and human CYP3A4

    • Z.-Y. Zhang
    • B. M. King
    • Y. N. Wong

    Original Article 23 April 2008 Pages: 707 - 716

    

18. Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation

    • Alessandra Fabi
    • Giulio Metro
    • Francesco Cognetti

    Clinical Trial Report 06 December 2007 Pages: 717 - 725

    

19. A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors

    • William Schelman
    • Sherry Morgan-Meadows
    • George Wilding

    Clinical Trial Report 03 January 2008 Pages: 727 - 733

20. Imatinib inhibition of fludarabine uptake in T-lymphocytes

    • Erica L. Woodahl
    • Joanne Wang
    • Jeannine S. McCune

    Short Communication 15 November 2007 Pages: 735 - 739

    

21. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient

    • Massimo Gentile
    • Eugenio Lucia
    • Fortunato Morabito

    Short Communcation 07 December 2007 Pages: 741 - 743